What is PEN's five-year median EV/EBITDA?

149.1x. Half of PEN's weekly readings over the last five years were higher and half were lower. This page has 555 weekly readings, from Mar 7, 2016 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares PEN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Penumbra Inc (PEN) valuation history

Health Care

$324.39

Latest weekly close · Market cap $12.8B

Below its usual range

As of Oct 24, 2026

PEN's EV/EBITDA of 59.6x is lower than 82% of its weekly readings over the last five years.

Weekly EV/EBITDA with its 5-year range

EV/EBITDA each weekMiddle half of the last 5 years5-year median 149.1×

5-year median: 149.1×
10-year median: 224.1×
5-year low to high: 47.7×–984.8×
Versus 5-year median: -60%

EV/EBITDA

18thpercentile

of its weekly readings over the last five years

Below its usual range

Growth, last 12 months vs the year before

Revenue: +18%accelerating
EPS: +8%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

PEN EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	61.5×	10
Dec 30, 2024	329.5×	66
Dec 25, 2023	137.4×	25
Dec 26, 2022	n/a	Too little history
Dec 27, 2021	234.6×	35
Dec 28, 2020	n/a	Too little history
Dec 30, 2019	110.3×	2
Dec 31, 2018	2,021.2×	90
Dec 25, 2017	n/a	Too little history
Dec 26, 2016	454.4×	Too little history

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare PEN with peers

Health Care peers of PEN on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
ABTAbbott Laboratories	18.9×	Within its usual range	38
BAXBaxter International	16.4×	Within its usual range	54
BSXBoston Scientific	14.4×	Historically low	2
DXCMDexcom	21.9×	Historically low	3
EWEdwards Lifesciences	30.0×	Within its usual range	42

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on PEN

No articles about PEN yet. How valuation percentiles work

Loading peers and related research…

About this history

What is PEN's current EV/EBITDA?: PEN's EV/EBITDA of 59.6x is lower than 82% of its weekly readings over the last five years.
What is PEN's five-year median EV/EBITDA?: 149.1x. Half of PEN's weekly readings over the last five years were higher and half were lower. This page has 555 weekly readings, from Mar 7, 2016 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares PEN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.